Paper 01 - A GLOBAL TREATMENT ACCESS PROGRAM FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMOR IN PREDOMINANTLY LOW- AND MIDDLE-INCOME COUNTRIES: A RETROSPECTIVE COHORT ANALYSIS

Author(s)

• 

  Michael J. Wagner, MD (he/him/his)

  Senior Physician
  Dana Farber Cancer Institute
  Boston, Massachusetts, United States

  Slides

Co-Author(s)

• 

  Edward L. Briercheck, MD/PhD (he/him/his)

  Physician
  Dana Farber Cancer Institute
  Boston, Massachusetts, United States
• JW

  J. Michael Wrigglesworth, B.A.

  The Max Foundation
  Seattle, Washington, United States
• PS

  Philip Stevenson, M.S.

  Fred Hutch Cancer Center
  Seattle, Washington, United States
• AA

  Alicia A. Annamalay, PhD

  The Max Foundation
  Seattle, Washington, United States
• DC

  David G. Coffey, M.D.

  University of Miami
  Miami, Florida, United States
• AA

  Aparna Anderson, PhD

  The Max Foundation
  Seattle, Washington, United States
• 

  Pat Garcia- Gonzalez, M.S.

  CEO
  The Max Foundation
  Seattle, Washington, United States